
Shreenath Paper Products Limited IPO Detail
Last Updated on February 22, 2025 Shreenath Paper Products Limited IPO Incorporated in 2011, Shreenath Paper Products Limited is engaged in offering supply chain solutions to industries that use paper
Incorporated in 2010, Dr. Agarwal’s Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
As of September 30, 2024, there were 737 doctors providing care to patients across the company’s facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.
The Services provided by the company are:-
Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;
Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).
Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.
As of September 30, 2024, the company’s Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).
As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.
Competitive Strength
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 | ||||||||||||||||||||||||||||||||||||
Revenue | 837.94 | 1,376.45 | 1,031.49 | 713.78 | ||||||||||||||||||||||||||||||||||||
Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 | ||||||||||||||||||||||||||||||||||||
Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 | ||||||||||||||||||||||||||||||||||||
Reserves and Surplus | 1,509.11 | 1,365.86 | 652.63 | 236.27 | ||||||||||||||||||||||||||||||||||||
Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 | ||||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
The market capitalization of Dr Agarwals Healthcare IPO is Rs 12698.37 Cr.
KPI as of Sun, Mar 31, 2024.
KPI | Values |
---|---|
ROE | 9.33% |
ROCE | 14.61% |
RoNW | 6.21 |
PAT Margin | 6.90 |
Price to Book Value | 7.96 |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 3.08 | 2.51 |
P/E (x) | 130.44 | 160.48 |
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
IPO Date | January 29, 2025 to January 31, 2025 |
Listing Date | [.] |
Face Value | ₹1 per share |
Price Band | ₹382 to ₹402 per share |
Lot Size | 35 Shares |
Total Issue Size | 7,53,04,970 shares (aggregating up to ₹3,027.26 Cr) |
Fresh Issue | 74,62,686 shares (aggregating up to ₹ 300.00 Cr) |
Offer for Sale | 6,78,42,284 shares of ₹1 (aggregating up to ₹2,727.26 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share Holding Pre Issue | 30,84,17,160 shares |
Share Holding Post Issue | 31,58,79,846 shares |
The Promoters of the Company are Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr Agarwal’s Eye Institute and Dr Agarwal's Eye Institute Private Limited
Share Holding Pre Issue | 37.72% |
Share Holding Post Issue | 32.50% |
Looking to invest ethically or according to Islamic principles? Expert Ethical brokers can help. Whether you need an ethical investment broker, a halal stock broker in India, or a Shariah-compliant broker, there are specialists available. Discover how to align your investments with your values and start your journey towards ethical wealth creation today through Ethical IAP or Ethical PMS.
Visit Prosperia.in to learn more about Ethical Investment Opportunities and start your journey towards ethical wealth creation today.
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on February 22, 2025 Shreenath Paper Products Limited IPO Incorporated in 2011, Shreenath Paper Products Limited is engaged in offering supply chain solutions to industries that use paper
Last Updated on February 22, 2025 Nukleus Office Solutions Limited IPO Incorporated in December 2019, Nukleus Office Solutions Limited offers co-working and managed office spaces in Delhi NCR, featuring furnished
Last Updated on February 20, 2025 Beezaasan Explotech Limited IPO Incorporated in August 2013, Beezaasan Explotech Limited manufactures and supplies a comprehensive range of explosives and explosive accessories. It primarily
Copyright © 2023 - Halalstock.in